134 related articles for article (PubMed ID: 19166820)
1. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression.
Chang CJ; Hsu CC; Yung MC; Chen KY; Tzao C; Wu WF; Chou HY; Lee YY; Lu KH; Chiou SH; Ma HI
Biochem Biophys Res Commun; 2009 Mar; 380(2):236-42. PubMed ID: 19166820
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
3. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
[TBL] [Abstract][Full Text] [Related]
4. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.
Zhang B; Sun J; Yu SP; Chen C; Liu B; Liu ZF; Ren BC; Ming HL; Yang XJ
Chin Med J (Engl); 2012 Dec; 125(24):4344-8. PubMed ID: 23253699
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor.
Kao CL; Huang PI; Tsai PH; Tsai ML; Lo JF; Lee YY; Chen YJ; Chen YW; Chiou SH
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):219-28. PubMed ID: 19362240
[TBL] [Abstract][Full Text] [Related]
6. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells.
Lehnus KS; Donovan LK; Huang X; Zhao N; Warr TJ; Pilkington GJ; An Q
Int J Oncol; 2013 Mar; 42(3):1011-7. PubMed ID: 23340741
[TBL] [Abstract][Full Text] [Related]
7. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
McCord AM; Jamal M; Williams ES; Camphausen K; Tofilon PJ
Clin Cancer Res; 2009 Aug; 15(16):5145-53. PubMed ID: 19671863
[TBL] [Abstract][Full Text] [Related]
8. IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.
Chen Y; Zhang F; Tsai Y; Yang X; Yang L; Duan S; Wang X; Keng P; Lee SO
Radiat Oncol; 2015 Nov; 10():227. PubMed ID: 26572130
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
Wang L; Long L; Wang W; Liang Z
J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
[TBL] [Abstract][Full Text] [Related]
10. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
12. [Effect of CD133(+) cells on the radiosensitivity of rectal cancer cells].
Qiu J; Yang G; Shen Z; Ding L; Wang D; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):103-8. PubMed ID: 24796457
[TBL] [Abstract][Full Text] [Related]
13. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.
Jamal M; Rath BH; Tsang PS; Camphausen K; Tofilon PJ
Neoplasia; 2012 Feb; 14(2):150-8. PubMed ID: 22431923
[TBL] [Abstract][Full Text] [Related]
14. Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
Kim MJ; Kim RK; Yoon CH; An S; Hwang SG; Suh Y; Park MJ; Chung HY; Kim IG; Lee SJ
J Cell Sci; 2011 Sep; 124(Pt 18):3084-94. PubMed ID: 21878493
[TBL] [Abstract][Full Text] [Related]
15. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
17. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
Nakai E; Park K; Yawata T; Chihara T; Kumazawa A; Nakabayashi H; Shimizu K
Cancer Invest; 2009 Nov; 27(9):901-8. PubMed ID: 19832037
[TBL] [Abstract][Full Text] [Related]
18. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C; Yan Z; Cao X; Zhang X; Yang L
J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
20. Insight into the complex regulation of CD133 in glioma.
Campos B; Herold-Mende CC
Int J Cancer; 2011 Feb; 128(3):501-10. PubMed ID: 20853315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
